BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26916621)

  • 21. Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System.
    Anderson JL; May HT; Lappé DL; Bair T; Le V; Carlquist JF; Muhlestein JB
    Am J Cardiol; 2016 Mar; 117(5):794-9. PubMed ID: 26772440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study).
    Buvat J; Montorsi F; Maggi M; Porst H; Kaipia A; Colson MH; Cuzin B; Moncada I; Martin-Morales A; Yassin A; Meuleman E; Eardley I; Dean JD; Shabsigh R
    J Sex Med; 2011 Jan; 8(1):284-93. PubMed ID: 20704642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of statins is associated with lower serum total and non-sex hormone-binding globulin-bound testosterone levels in male participants of the Rotterdam Study.
    de Keyser CE; de Lima FV; de Jong FH; Hofman A; de Rijke YB; Uitterlinden AG; Visser LE; Stricker BH
    Eur J Endocrinol; 2015 Aug; 173(2):155-65. PubMed ID: 26034077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency.
    Cheetham TC; An J; Jacobsen SJ; Niu F; Sidney S; Quesenberry CP; VanDenEeden SK
    JAMA Intern Med; 2017 Apr; 177(4):491-499. PubMed ID: 28241244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues.
    Poels S; Bloemers J; van Rooij K; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
    J Sex Med; 2013 Mar; 10(3):810-23. PubMed ID: 23130748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
    Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
    Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction.
    Corona G; Boddi V; Balercia G; Rastrelli G; De Vita G; Sforza A; Forti G; Mannucci E; Maggi M
    J Sex Med; 2010 Apr; 7(4 Pt 1):1547-56. PubMed ID: 20141585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [65-month testosterone replacement therapy for androgen deficiency-induced ED: a case report and review of the literature].
    Jiang T; Zheng L; Sun DC; Li QL; Zhang ZW; Wang FP; Wang QF; Jiang H
    Zhonghua Nan Ke Xue; 2014 Feb; 20(2):152-5. PubMed ID: 24520668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
    Wallis CJ; Lo K; Lee Y; Krakowsky Y; Garbens A; Satkunasivam R; Herschorn S; Kodama RT; Cheung P; Narod SA; Nam RK
    Lancet Diabetes Endocrinol; 2016 Jun; 4(6):498-506. PubMed ID: 27165609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
    Miner M; Canty DJ; Shabsigh R
    Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
    Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM
    Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perioperative statin therapy reduces mortality in normolipidemic patients undergoing cardiac surgery.
    Vaduganathan M; Stone NJ; Lee R; McGee EC; Malaisrie SC; Silverberg RA; Kansal P; McCarthy PM
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1018-27. PubMed ID: 20851427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MYTHS AND CONTROVERSIES IN HYPOGONADISM TREATMENT OF AGING MALES.
    Ungureanu MC; Costache II; Preda C; Mogoş V; Vulpoi C; Leuştean L
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):325-33. PubMed ID: 26204632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of statins and the risk of death in patients with prostate cancer.
    Yu O; Eberg M; Benayoun S; Aprikian A; Batist G; Suissa S; Azoulay L
    J Clin Oncol; 2014 Jan; 32(1):5-11. PubMed ID: 24190110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for hypogonadism in diabetes 2008/9: results from the Cheshire Primary Care cohort.
    Anderson SG; Heald A; Younger N; Bujawansa S; Narayanan RP; McCulloch A; Jones H
    Prim Care Diabetes; 2012 Jul; 6(2):143-8. PubMed ID: 21982717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do statins affect androgen levels in men? Results from the Boston area community health survey.
    Hall SA; Page ST; Travison TG; Montgomery RB; Link CL; McKinlay JB
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1587-94. PubMed ID: 17684132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and prognosis of a low serum testosterone in men with type 2 diabetes: the Fremantle Diabetes Study Phase II.
    Hamilton EJ; Davis WA; Makepeace A; Lim EM; Yeap BB; Peters KE; Davis TM
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):444-52. PubMed ID: 27106511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Phosphodiesterase-5 Inhibitors Versus Alprostadil With Survival in Men With Coronary Artery Disease.
    Andersson DP; Landucci L; Lagerros YT; Grotta A; Bellocco R; Lehtihet M; Holzmann MJ
    J Am Coll Cardiol; 2021 Mar; 77(12):1535-1550. PubMed ID: 33766260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.